Scripps Research Institute Study Underlines Potential of New Technology to Diagnose Disease
Tuesday, March 26, 2013
The novel method points to new blood tests for conditions from Alzheimer’s to autoimmune diseases.
Vermillion Appoints Bruce A. Huebner as Interim CEO
Monday, March 25, 2013
Huebner will continue to serve on Vermillion's board of directors.
Bio-Rad Receives Award for QX100 Droplet Digital PCR System
Thursday, March 14, 2013
Company receives Frost & Sullivan 2012 North American Laboratory Researchers’ Choice: Future market leader of digital PCR technology award.
Toray Makes $5 Million Strategic Investment in Spectral Diagnostics
Monday, March 11, 2013
Private placement expected to close at the beginning of April, 2013.
Curetis AG Strengthens Commercial Team and Expands Distribution Network
Monday, March 11, 2013
Appointment of Helmut Hilbert as Head of Business Development.
GBD Receives Wellcome Trust Support for Development of New TB Diagnostic
Wednesday, March 06, 2013
Company has received a £2.6m($4.3m) strategic translation award from the Wellcome Trust.
Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis
Tuesday, March 05, 2013
Alere Inc. announced that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill & Melinda Gates Foundation.
Lab21 and IntegraGen Partner
Tuesday, March 05, 2013
Lab21 Limited has entered into an agreement with IntegraGen to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes.
Newly Launched RIQAS Website Makes EQA Even Simpler for Laboratories Worldwide
Monday, March 04, 2013
www.riqas.com allows users to easily discover the many benefits offered by the world’s largest External Quality Assessment (EQA) scheme, Randox International Quality Assessment Scheme (RIQAS) and the advantages of implementing EQA in their laboratory.
|
|
|
|
|
|
